News Image

Get insights into the top gainers and losers of Monday's after-hours session.

By Mill Chart

Last update: Apr 8, 2024

Get insights into the top gainers and losers of Monday's after-hours session.

After hours gainers

TickerChangeComment
BENF28.92%BENEFICIENT - CLASS A (NASDAQ:BENF) rose 28.92% to $0.11 during Monday's after hours session. After a notable 61.17% gain earlier today, NASDAQ:BENF maintains its positive momentum during the after-hours session.
KITT21.84%Positive market activity for NAUTICUS ROBOTICS INC (NASDAQ:KITT) after regular trading hours, with a 21.84% increase to $0.32 in the after-hours session on Monday. NASDAQ:KITT released their earnings today. In the last 3 months the share price dropped with 50.57%.
KA16.67%Positive after-hours movement for KINETA INC (NASDAQ:KA) as its shares recorded a 16.67% increase, reaching $0.63 during Monday's after-hours session. In the last month the share price dropped with 22.3%.
WINT14.63%WINDTREE THERAPEUTICS INC's (NASDAQ:WINT) shares rose 14.63% to $0.47 during Monday's after hours session. In the last 3 months the stock lost 28.35%.
AEHL9.25%ANTELOPE ENTERPRISE HOLDINGS (NASDAQ:AEHL) rose 9.25% to $1.66 during Monday's after hours session. In the last 6 months the share price dropped with 42.64%.
GNLN7.84%GREENLANE HOLDINGS INC - A (NASDAQ:GNLN) showcases remarkable after-hours performance, with a 7.84% rise to $0.55 during Monday's after-hours trading. In the last 6 months the stock lost 21.72%.
ASST7.69%ASSET ENTITIES INC-B (NASDAQ:ASST) showcases remarkable after-hours performance, with a 7.69% rise to $0.42 during Monday's after-hours trading. In the last month the stock lost 32.76%.
ALLR6.93%After the closing bell, ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) demonstrated strong momentum in the after-hours session, with a 6.93% rise to $0.23. In the last month the stock lost 46.37%.
BCLI6.63%BRAINSTORM CELL THERAPEUTICS (NASDAQ:BCLI) rose 6.63% to $0.78 during Monday's after hours session. Today's gain of 12.14% continues in today's after hours session with 6.63%.
CHSN6.56%Notable gains for CHANSON INTERNATIONAL HOLD-A (NASDAQ:CHSN) in the after-hours session, with a 6.56% rise to $1.95 during Monday. The stock is trading 39.69% higher than 3 months ago.

To see the full list of after hours gainers you can use our after hours gainers page.

After hours losers

TickerChangeComment
VINC-44.77%Following a -13.87% loss in the regular session, NASDAQ:VINC exhibits further decline during today's after-hours session. Following a -13.87% loss in the regular session, NASDAQ:VINC sees no respite as the after-hours session continues the downward trajectory.
WTO-17.2%UTIME LTD's (NASDAQ:WTO) stock price saw a decrease of 17.2% to $0.25 during Monday's after-hours session. Prices are quite volatile now: this is a reversal from 62.16% gain.
SMFL-8.83%SMART FOR LIFE INC's (NASDAQ:SMFL) shares experienced a 8.83% decrease to $0.63 in the after-hours session. Price movements remain volatile as NASDAQ:SMFL gives back 38.88% of its earlier gains in the after-hours session.
MAXN-8.8%MAXEON SOLAR TECHNOLOGIE's (NASDAQ:MAXN) stock price decreased by 8.8% to $2.49. In the last month the stock lost 26.02%.
TPET-8.54%Price volatility persists as NYSEARCA:TPET closed the regular session with a %ABSPERF% loss, and the downward trend continues in the after-hours session. The stock is trading 40.4% higher than a month ago.
BSGM-8.47%BIOSIG TECHNOLOGIES INC's (NASDAQ:BSGM) stock price is showing a decline of 8.47% to a price of $1.14 during the after-hours session. After registering a 91.56% gain earlier today, NASDAQ:BSGM is experiencing a 8.47% decline in today's after-hours session.
STRC-6.91%The after-hours session reflects NASDAQ:STRC's ongoing correction after experiencing a 27.46% loss in the regular trading hours. Price volatility intensifies as NASDAQ:STRC retraces its 27.46% gain during the after-hours session. A press release (Palladyne AI Ticker Symbol now PDYN) was released yesterday.
OPGN-6.14%Price volatility persists as NASDAQ:OPGN closed the regular session with a %ABSPERF% loss, and the downward trend continues in the after-hours session. In the last month the share price increased with 47.17%.
RELI-5.53%Following a -12.63% loss in the regular session, NASDAQ:RELI exhibits further decline during today's after-hours session. The after-hours session reflects NASDAQ:RELI's ongoing correction after a -12.63% loss in the regular trading hours.
GLMD-5.28%GALMED PHARMACEUTICALS LTD's (NASDAQ:GLMD) stock price saw a decrease of 5.28% to $0.38 during Monday's after-hours session. After registering a 16.72% gain earlier today, NASDAQ:GLMD is experiencing a 5.28% decline in today's after-hours session.

To see the full list of after hours losers you can use our after hours losers page.

Back

BRAINSTORM CELL THERAPEUTICS

NASDAQ:BCLI (4/29/2024, 5:49:33 PM)

0.54

+0.01 (+1.03%)

BCLI News

News Image13 days ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

News Image19 days ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI, "the Company"), a leading developer of cellular therapies for neurodegenerative diseases,...

News Image20 days ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the...

News Image20 days ago - ChartmillTop movers in Tuesday's after hours session

Get insights into the top gainers and losers of Tuesday's after-hours session.

News Image20 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!

News Image21 days ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

News Image22 days ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics to Provide Update on NurOwn Program

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...

News Imagea month ago - InvestorPlaceBCLI Stock Earnings: Brainstorm Cell Beats EPS for Q4 2023

BCLI stock results show that Brainstorm Cell beat analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

News Image2 months ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific Conference

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

News Image2 months ago - Seeking AlphaBrainStorm submits SPA request to FDA for Phase 3 study design (NASDAQ:BCLI)

BrainStorm Cell Therapeutics (BCLI) said it has submitted a Special Protocol Assessment request to the FDA for a Phase 3b study of its cell therapy NurOwn in the treatment of ALS.

News Image2 months ago - BrainStorm Cell Therapeutics Inc.BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALS

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

BCLI Links
Follow us for more